TSE:6407 stock news
This page provides real-time market news, earnings updates, and company announcements related to CKD Corporation (TSE:6407).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-15 07:03 JST
Kyntra Bio to Report Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-09 11:03:47
Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on Thursday, March 12, 2026
Finviz2026-03-09 12:03:09
Mineralys Therapeutics Announces FDA Acceptance of NDA for Lorundrostat for Treatment of Adults with Hypertension and Topline Explore-OSA Trial Results
Finviz2026-03-09 20:40:44
Lexicon to Present Data on Effect of Kidney Function on the Long-term Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes at 19th International Conference on Advanced Technologies & Treatments for Diabetes
Finviz2026-03-11 12:03:50
Mineralys Shares Climb After FDA Accepts NDA for Blood Pressure Medication
101 finance2026-03-11 16:40:47
Ardelyx Announces Recipients of the 2026 Derek Forfang Patient Advocate Award
Finviz2026-03-12 12:03:52
Mineralys Therapeutics Reports Fourth Quarter 2025 Financial Results and Provides Corporate Update
Finviz2026-03-12 20:09:51
Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-16 20:09:45
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-16 20:09:46
ProKidney Reports Full Year 2025 Financial Results and Business Highlights
Finviz2026-03-18 20:03:08
AstraZeneca’s China CKD Registry Could Fast-Track Nephrology Market Access via Real-World Evidence Edge
101 finance2026-03-19 16:57:42
Mineralys Therapeutics Appoints Jeffrey A. Munsie as Chief Legal Officer
Finviz2026-03-24 12:03:49
20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare to Integrate Advanced CKD Prediction Technology into Its Longevity Test Program
Finviz2026-03-24 12:33:49
Maze Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights
Finviz2026-03-25 11:03:53
ProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial Officer
Finviz2026-03-25 20:03:48
Keenova's TERLIVAZ Faces Existential Test: Can Real-World Data Justify $4.5M Valuation?
101 finance2026-03-27 11:54:43
Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-30 11:09:44
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair (omalizumab)
Finviz2026-03-30 12:03:47
Data presented at ACC.26 further demonstrate the benefits of iRhythm's Zio ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform
Finviz2026-03-30 12:09:42
Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study
Finviz2026-03-30 13:09:49
DiaMedica Therapeutics’ 2025 Earnings Calls Contradict Stroke Enrollment Rates, U.S. Trial Timelines
101 finance2026-03-31 13:24:41
Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board
Finviz2026-04-06 13:00:53
Revelation Biosciences Approaches Critical Juncture as Gemini Study Finalizes and Funding Timeline Tightens
101 finance2026-04-06 13:33:43
Kyntra Bio to Present at the 25th Annual Needham Virtual Healthcare Conference
Finviz2026-04-08 20:09:50
Mineralys Shares Climb After FDA Accepts NDA for Blood Pressure Medication
101 finance2026-03-11 16:40:47
Ardelyx Announces Recipients of the 2026 Derek Forfang Patient Advocate Award
Finviz2026-03-12 12:03:52
Mineralys Therapeutics Reports Fourth Quarter 2025 Financial Results and Provides Corporate Update
Finviz2026-03-12 20:09:51
Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-16 20:09:45
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-16 20:09:46
ProKidney Reports Full Year 2025 Financial Results and Business Highlights
Finviz2026-03-18 20:03:08
AstraZeneca’s China CKD Registry Could Fast-Track Nephrology Market Access via Real-World Evidence Edge
101 finance2026-03-19 16:57:42
Mineralys Therapeutics Appoints Jeffrey A. Munsie as Chief Legal Officer
Finviz2026-03-24 12:03:49
20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare to Integrate Advanced CKD Prediction Technology into Its Longevity Test Program
Finviz2026-03-24 12:33:49
Maze Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights
Finviz2026-03-25 11:03:53
ProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial Officer
Finviz2026-03-25 20:03:48
Keenova's TERLIVAZ Faces Existential Test: Can Real-World Data Justify $4.5M Valuation?
101 finance2026-03-27 11:54:43
Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-30 11:09:44
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair (omalizumab)
Finviz2026-03-30 12:03:47
Data presented at ACC.26 further demonstrate the benefits of iRhythm's Zio ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform
Finviz2026-03-30 12:09:42
Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study
Finviz2026-03-30 13:09:49
DiaMedica Therapeutics’ 2025 Earnings Calls Contradict Stroke Enrollment Rates, U.S. Trial Timelines
101 finance2026-03-31 13:24:41
Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board
Finviz2026-04-06 13:00:53
Revelation Biosciences Approaches Critical Juncture as Gemini Study Finalizes and Funding Timeline Tightens
101 finance2026-04-06 13:33:43
Kyntra Bio to Present at the 25th Annual Needham Virtual Healthcare Conference
Finviz2026-04-08 20:09:50
TSE:6407 stock price change
On the last trading day, TSE:6407 stock closed at 5740.00 JPY, with a price change of 1.59% for the day.
Trade stock perpsTSE:6407 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more